CatalystPit

VCELVericel Corp

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $40.14 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$2.06B
CountryUSA
RECENT INSIDER TRADES
  • 2026-08-14 · MCLAUGHLIN KEVIN F (Director) · OTHER
  • 2026-08-14 · MCLAUGHLIN KEVIN F (Director) · SELL
  • 2026-08-05 · Halpin Michael (Chief Operating Officer) · SELL
  • 2026-07-31 · SIEGAL JONATHAN (Principal Accounting Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders345
Shares held68,415,003
Value$2.92B
Percent of shares outstanding133.61%
As of quarter end2026-06-30
RECENT NEWS
  • Vericel presents at Morgan Stanley 24th Annual Global Healthcare Conference
  • Vericel offers MACI for regenerative knee cartilage
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS